This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BIO-Europe Spring

Early Bird pricing expires in:

  • 00
    DAYS
  • 00
    HRS
  • 00
    MINS
  • 00
    SECS
Delivered In-Person & Digitally
March 28–30, 2022, Basel, SwitzerlandApril 4–6, 2022, Digital Partnering

FasT Biopharma

Profile

Fast Biopharma, a UK company based in Oxford and Alderley Park, seeks to address the failure of checkpoint inhibitor therapy in the majority of cancer patients by targeting T-cell death. Fas ligand is expressed on multiple cell types within the microenvironment of certain solid tumours and is thought to be a major limiter of activated T-cell trafficking and persistence. Our first-in-class anti-fasL antibody, FBP002, is an ideal humanised antibody to progress this concept into the clinic.